Forest Tries To Block Plaintiff In Celexa/Lexapro Suits

Law360, New York (June 18, 2007, 12:00 AM EDT) -- Forest Laboratories Inc. has urged a judge to deny the request of one of the plaintiffs in the multidistrict litigation involving blockbuster antidepressant drugs Celexa and Lexapro, arguing that time limitations prevent the addition of a Forest subsidiary to the complaint.

On Friday, Forest entered a motion in the U.S. District Court for the Eastern District of Missouri, hoping that the court will reject Mark Bibbee's demand to amend the wrongful death suit filed in the wake of his relatives' deaths.

“Plaintiff's request is futile because...
To view the full article, register now.




Case Information

Case Title

In Re: Celexa and Lexapro Products Liability Litigation

Case Number



Missouri Eastern

Nature of Suit

Personal Inj. Prod. Liability


Rodney W. Sippel

Date Filed

February 17, 2006


Government Agencies

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.